|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 托伐普坦(一种口服的血管加压素拮抗剂)对心力衰竭住院患者的短期临床作用:EVEREST临床状况试验 | Gheorghiade M. Konstam M.A. Burnett Jr. J.C. 杜媛 | 2007 | 世界核心医学期刊文摘(心脏病学分册)2007，0，8： | 5 |
| 2 | 血管加压素拮抗剂Tolvaptan对院内心力衰竭患者的疗效:随机对照试验显示文摘背景:美国每年约有一百万人因慢性心力衰竭而入院,多数与充血性心力衰竭恶化有关。利尿剂是充血性心力衰竭的主要治疗手段,可导致电解质紊乱和肾功能恶化。与利尿剂不同,血管加压素拮抗剂tolvaptan在减少心力衰竭患者血容量的同时对电解质和肾功能无副作用。 | Mihai Gheorghiade Wendy A. Gattis Christopher M. O'Connor 范琰(译) 刘梅林(校) | 2005 | 美国医学会杂志(中文版)2005，24，4： | 3 |
| 3 | Vasopressin Receptor Antagonists for the Treatment of Hyponatremia: Systematic Review and Meta-analysis显示文摘 | Benaya Rozen-Zvi Dafna Yahav Mihai Gheorghiade Asher Korzets Leonard Leibovici Uzi Gafter | 2010 | American Journal of Kidney Diseases2010，，2： | 3 |
| 4 | 口服托伐普坦对心力衰竭恶化住院患者的效果:EVEREST预后试验 | Konstam M.A. Gheorghiade M. Burnett Jr. J.C. 杜媛 | 2007 | 世界核心医学期刊文摘(心脏病学分册)2007，0，8： | 2 |
| 5 | Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial显示文摘 | Ali Ahmed Michael W. Rich Jerome L. Fleg Michael R. Zile James B. Young Dalane W. Kitzman Thomas E. Love Wilbert S. Aronow Kirkwood F. Adams Mihai Gheorghiade | 2006 | Circulation2006，，5： | 2 |
| 6 | Vasopressin Antagonism in Heart Failure显示文摘 | Steven R. Goldsmith Mihai Gheorghiade | 2005 | Journal of the American College of Cardiology2005，，10： | 2 |
| 7 | n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion: A Prospective, Randomized Study显示文摘 | Savina Nodari Marco Triggiani Umberto Campia Alessandra Manerba Giuseppe Milesi Bruno M. Cesana Mihai Gheorghiade Livio Dei Cas | 2011 | Circulation2011，，10： | 2 |
| 8 | Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure显示文摘 | Gregg C. Fonarow Wendy Gattis Stough William T. Abraham Nancy M. Albert Mihai Gheorghiade Barry H. Greenberg Christopher M. O'Connor Jie Lena Sun Clyde W. Yancy James B. Young | 2007 | Journal of the American College of Cardiology2007，，8： | 2 |
| 9 | Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure显示文摘 | Gregg C. Fonarow Wendy Gattis Stough William T. Abraham Nancy M. Albert Mihai Gheorghiade Barry H. Greenberg Christopher M. O’Connor Jie Lena Sun Clyde W. Yancy James B. Young | 2007 | Journal of the American College of Cardiology2007，，8： | 2 |
| 10 | Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial显示文摘 | Ali Ahmed Michael W. Rich Jerome L. Fleg Michael R. Zile James B. Young Dalane W. Kitzman Thomas E. Love Wilbert S. Aronow Kirkwood F. Adams Mihai Gheorghiade | 2006 | Circulation2006，，5： | 2 |
| 11 | Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial显示文摘 | GHEORGHIADE M GA337S WA O'CONNOR CM | 2004 | JAMA2004，291，16： | 1 |
| 12 | Chronic heart failure in the United States:a manifestation of coronary artery disease显示文摘 | Gheorghiade M Bonow RO | 1998 | Circulation1998，97，3： | 1 |
| 13 | Vasopressin Vrreceptor blockade 'with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial显示文摘 | GHEORGHIADE M NIAZI I OUYANG J | 2003 | Circulation2003，107，21： | 1 |
| 14 | Sur-rogate end points in heart failure trials显示文摘 | Gheorghiade M Adams K F Jr Gattis W A | 2003 | Am Heart J2003，145，2： | 1 |
| 15 | Vasopressin: a new target for the treatment of heart failure显示文摘 | Craig R Lee Michael L Watkins J.Herbert Patterson Wendy Gattis Christopher M O'Connor Mihai Gheorghiade Kirkwood F Adams | 2003 | American Heart Journal2003，，1： | 1 |
| 16 | Short-term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST Clinical Status Trials显示文摘 | Gheorghiade M Konstam M A Burnett J J | 2007 | JAMA2007，297，12： | 1 |
| 17 | Acute Heart Failure With Low Cardiac Output: Can We Develop a Short-term Inotropic Agent That Does Not Increase Adverse Events?显示文摘 | Umberto Campia Savina Nodari Mihai Gheorghiade | 2010 | Current Heart Failure Reports2010，，3： | 1 |
| 18 | Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future Aims: A Scientific Statement From the American Heart Association显示文摘 | Neal L. Weintraub Sean P. Collins Peter S. Pang Phillip D. Levy Allen S. Anderson Cynthia Arslanian-Engoren W. Brian Gibler James K. McCord Mark B. Parshall Gary S. Francis Mihai Gheorghiade | 2010 | Circulation2010，，： | 1 |
| 19 | Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial显示文摘 | MARVIN K GHEORGHIADE M JR J | 2007 | JAMA2007，297，12： | 1 |
| 20 | Tolvaptan, a selective oral vasopressin V2 receptor antagonist, for hyponatremia显示文摘 | Schrier RW Gross P Gheorghiade M | 2006 | N Engl J Med2006，355，20： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员